e12510 Background: Cervical cancer (CC) represents an important public health problem in Brazil being the second most common cancer in women. The expected incidence rate in 2012 was 17.5 per 100,000 women while the age-standardized mortality rate in 2010 was 4.04 per 100,000 women. Inequities in access to health preventive programs contribute to this figure. The goal of this analysis is to identify inequities in Pap smear screening in women from urban and rural populations from Brazil. Methods: Using the Health Supplement of the National Household Sample Survey 2008 (PNAD) with 102,108 Brazilian women aged 25-64 years Pap smear screening was analyzed dichotomously as women having ever or never been screened. Residence area was categorized as urban or rural. Age-adjusted prevalence of never-screened was analyzed using chi-squared test. Poisson regression modeling, crude and full adjusted for age, income, number of children, education, skin color, having visited a physician in the previous 12 months and healthcare insurance were performed for Brazil in general and for Brazilian major regions. Results: The prevalence of never-screened women for CC was 12.9% in Brazil, 11.5% in urban and 22.2% in rural areas. The poorest Brazilian major-regions showed the highest prevalence of never-screened women: North (17.4% in general, 14.7% in urban and 27.3% in rural areas) and Northeast (14.7% in general, 12.8% in urban and 23.7% in rural areas). After full-adjustment, the rural population showed a higher relative risk for never-screened as compared to those living in urban areas [PR=1.23 (95%CI 1.14; 1.31); p<0,001]. The highest risk was also found in the North [PR=1.39 (1.13; 1.31); p=0.002]. However, South and Central-west regions showed no association between never-screened and area [PR=1.06 (0.88; 1.28); p=0.541; PR=1.18 (0.87; 1.58); p=0.270, respectively]. Conclusions: Our findings point out inequities in Pap smear screening between Brazilian urban and rural population. These inequities possibly contribute to the high incidence and mortality rate of CC in Brazil.